BCM
CMRX

Bayesian Capital Management’s Chimerix, Inc. CMRX Stock Holding History

Bayesian Capital Management’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-58,936
Closed -$114K – 1077
2022
Q3 		$114K Buy
+58,936
New +$132K 0.02% 584
2022
Q2 		– Sell
-16,600
Closed -$76K – 1143
2022
Q1 		$76K Buy
+16,600
New +$92.5K 0.01% 714

Other funds holding CMRX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bayesian Capital Management's CMRX Position: Q4 2022 in Review

Bayesian Capital Management sold out of Chimerix, Inc. (CMRX) in Q4 2022, closing a stake of 58,936 shares — an estimated $114K sold.

Bayesian Capital Management first reported a position in CMRX in Q1 2022 and held it in 2 quarters. The position peaked at $114K in Q3 2022. 108 funds tracked by Wall St. Rank hold CMRX as of Q4 2022.

  • Bayesian Capital Management reported no remaining Chimerix, Inc. position as of Q4 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 58,936 Chimerix, Inc. shares in Q4 2022, an estimated $114K.
  • Bayesian Capital Management first reported a position in Chimerix, Inc. in Q1 2022 and held it in 2 quarters.
  • Bayesian Capital Management's Chimerix, Inc. position peaked at $114K in Q3 2022.
  • 108 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q4 2022.

Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.